Article
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
5 Jul 2014
Abstract excerpt
BACKGROUND: Docetaxel resistance remains a major obstacle in the treatment of non-small cell lung cancer (NSCLC). High-mobility group box 1 (HMGB1) has been shown to promote autophagy protection in response to antitumor therapy, but the exact molecular mechanism underlying HMGB1-mediated autophagy has not been clearly defined. METHODS: Lung adenocarcinoma (LAD) cells were transfected with pcDNA3.1-HMGB1 or HMGB1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
